Strong market-implied odds against a new pandemic in 2026 reflect the absence of any novel pathogen exhibiting sustained global human-to-human transmission or meeting WHO criteria for pandemic declaration as of mid-2026. Official CDC and WHO surveillance through June shows only localized clusters, including a May hantavirus outbreak linked to a cruise ship with limited secondary spread and no evidence of efficient airborne transmission. Broader monitoring of threats like Ebola Bundibugyo virus, dengue, and avian influenza variants indicates contained incidence rates consistent with historical baselines rather than exponential growth. Enhanced global health security systems and event-based surveillance continue to detect and isolate cases early, reducing escalation risk, though seasonal factors and potential variant emergence remain variables tracked in upcoming agency reports.